Arbutus Biopharma Corp (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.90
-2.30%
Mkt Cap $997.57M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+73.6%
Consensus $8.50 vs current $4.90
NASDAQ·Healthcare·Biotechnology
$4.90
-2.30%
Mkt Cap $997.57M
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+73.6%
Consensus $8.50 vs current $4.90